posted on 2018-05-29, 00:00authored byMarta K. Dudek, Maciej Kostrzewa, Piotr Paluch, Marek J. Potrzebowski
(S)-N-{2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide (Apremilast, APR), a novel anti-inflammatory
drug used in psoriasis (Ps) and psoriatic arthritis (PsA) treatment,
forms in the solid state well organized structures with a π-philic
pocket susceptible to aromatic–aromatic interactions. It has
been proven that such specific arrangement is preserved even after
melting the APR sample. The empty π-philic APR pocket can be
filled with different small molecules (dichloromethane, ethyl acetate,
acetonitrile, toluene, benzene, pyridine) by means of mechanochemical
grinding forming appropriate solvatomorphs; however, the strong preference
for favorable interactions with aromatic species is unquestionable.
During grinding of APR with a mixture of solvents (dichloromethane,
acetonitrile, toluene), only toluene is embedded into the crystal
lattice. Hence, it has been concluded that APR in the solid state
behaves as a selective π-philic mechanoreceptor. The strong
tendency for π-philic molecular recognition was employed in
a mechanochemical process as a driving force for the formation of
pharmaceutical cocrystals with coformers, which belong to the group
of aromatic natural products (catechol, pyrogallol, resorcinol). The
obtained cocrystals were characterized by advanced one-dimensional
and two-dimensional solid state NMR techniques, differential scanning
calorimetry, and powder X-ray diffraction. The molecular structure
of APR/catechol cocrystal was refined employing an NMR crystallography
approach, comparing the set of experimental NMR data (1H δiso, 13C δiso) with
computed shielding parameters calculated by means of the GIPAW method.